Abattis Bioceuticals Corp. (ATTBF)

Market Cap	476.00
Revenue (ttm)	269.58K +4,163.2%
Net Income	-2.30M
EPS	-0.00
Shares Out	476.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	206,177
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-54.59
RSI	48.18
Earnings Date	n/a

About Abattis Bioceuticals

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 201...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATTBF

Financial Performance

In fiscal year 2019, Abattis Bioceuticals's revenue was 356,876, an increase of 4163.24% compared to the previous year's 8,371. Losses were -3.04 million, -96.10% less than in 2018.

Financial numbers in CAD